The Technical Analyst
AdvisorShares Pure US [MSOS]
Exchange: NYSE
AdvisorShares Pure US Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.79% $8.96
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 311.12 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 146.33 mill |
| Avg Daily Volume: | 9.95 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 8.33 - 9.59 ( +/- 7.05%) |
| ATR Model: 14 days |
Forecast:
16:00 - $8.99
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $8.99
Forecast 2: 16:00 - $8.99
Forecast 3: 16:00 - $8.99
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $8.96 (0.79% ) |
| Volume | 8.12 mill |
| Avg. Vol. | 9.95 mill |
| % of Avg. Vol | 81.60 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MSOS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MSOS
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Latest Press Releases
2021-05-21 07:00:00 - Press Release
Gage Growth Corp. Announces Inclusion In Leading Cannabis Etf
Detroit, may 21, 2021 /prnewswire/ - gage growth corp. (cse: gage) ("gage" or the "company"), a leading high-quality craft cannabis brand and operator in michigan, is pleased to announce that it has been included in a leading cannabis focused exchange-traded fund ("etf"), advisorshares pure us cannabis etf (nyse:msos). "inclusion in a leading etf brings strong exposure to potential new investors and we are pleased the advisorshares etf has initiated a position in our company.
2021-01-26 07:05:00 - Press Release
Hempfusion Announces Inclusion In Leading Cannabis Etfs
Denver--(business wire)---- $cbd.u #cbd--hempfusion wellness inc. (tsx:cbd.u) (fwb:8oo) (“hempfusion” or the “company”) is pleased to announce that it has been included in two leading cannabis & hemp-derived cbd focused exchange-traded funds (“etfs”), advisorshares pure us cannabis etf (nyse:msos) and advisorshares pure cannabis etf (nyse:yolo). advisorshares is a leading sponsor of actively managed etfs. pure us cannabis etf (msos) is the only us-listed etf dedicated solely to us cannabis exposure, with o
Latest News
2024-05-07 17:46:42 - ETF Trends
Reclassification Reports Fueling U.S. Marijuana Investing
New reported plans by the U.S. government could pave the pay for profit in marijuana investing. The White House is reportedly seeking to reclassify marijuana from a Schedule I drug to a Schedule III.
2024-05-07 17:46:40 - ETF Trends
Thematic ETF Winners of the Q1 2024 Earnings Season
Digging into the first quarter's earnings season allows us to uncover the winning themes of the period as captured by ETFs.
2024-05-03 23:43:06 - Seeking Alpha
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.
2024-05-03 15:26:03 - Zacks Investment Research
Cannabis ETF (MSOS) Hits New 52-Week High
AdvisorShares Pure US Cannabis ETF ( MSOS ) is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 137.66% from its 52-week low price of $4.78/share.
2024-04-30 20:49:00 - Market Watch
U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance
WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.
2024-04-30 17:41:34 - Skynews
US plans to reclassify cannabis as less dangerous drug
The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.
2024-04-30 17:38:43 - Schwab Network
Pot Stocks Rally as DEA Moves to Reclassify Marijuana as Less Dangerous Drug
Pot stocks rally as the DEA moves to reclassify marijuana as a less dangerous drug. Renita Young discusses this as the DEA's proposal needs to be reviewed by the White House Office of Management and Budget.
2024-04-30 16:52:26 - Bloomberg Markets and Finance
DEA to Reclassify Marijuana | Daily Stock Market Wrap 4/30
The stock market sank in the final stretch of April and bond yields climbed on concern that stubborn inflation will force the Federal Reserve to keep interest rates higher for longer. On the eve of the Fed decision, a broad gauge of US labor costs closely watched by policymakers jumped the most in a year.
2024-04-30 15:12:39 - Reuters
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.
2024-04-30 14:40:21 - CNBC
Cannabis stocks surge as Biden administration moves to reclassify marijuana
